Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm.
PMID 41701761 · PMC12928580 · PLoS computational biology · 2026 · 8 claims · 5 setups
Driver2Comm is a computational framework that identifies intrinsic-extrinsic (IE) pathways functionally connecting cancer cell driver genes with their associated CCC signatures in the TME using single-cell transcriptomics data.
-
Full-text index only
The complement system contributes to the immunosuppressive microenvironment of uveal melanoma.
PMID 41803879 · PMC13130498 · Journal of translational medicine · 2026 · 8 claims · 8 setups
Primary UM (pUM) preferentially expresses early complement pathway components over terminal membrane attack complex elements, with early factors showing prognostic significance.
-
Full-text index only
Estrogen Production in Pancreatic Cancer Shapes a Tumor-Suppressive Stromal Microenvironment.
PMID 41258799 · PMC12862343 · Cancer research · 2026 · 8 claims · 6 setups
Serum levels of stromal biomarkers associated with favorable outcomes were significantly higher in female patients with PDAC than in male patients
-
Full-text index only
Ectopic expression of BEX genes in T-cell acute lymphoblastic leukemia.
PMID 40811813 · PMC12830129 · Blood advances · 2026 · 6 claims · 8 setups
Bex1 (and to a lesser extent Bex4) is ectopically expressed in Pten-deficient mouse T-ALL blasts
-
Full-text index only
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers.
PMID 41564862 · PMC12866174 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
A 19-factor cancer-immunoinstructive secretory signature (CISS) is present across multiple human cancers and correlates with pro-tumorigenic tumor microenvironments and poor patient survival.